Judith L Gulikers (J L Gulikers)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

British journal of cancer

Biomedical chromatography : BMC

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer 131 (3) (2024)
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer 131 (3) (2024)
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer (2024)
Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, Kristien Winckers, Yvonne Henskens, Jenneke Leentjens, Michel M van den Heuvel, Rob Ter Heine, Sander Croes, Berber Piet, Robin M J M van Geel
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British journal of cancer 131 (3) (2024)
Judith L Gulikers, A J van Veelen, J H M Driessen, P C Souverein, V C G Tjan-Heijnen, L E L Hendriks, R M J M van Geel, S Croes
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD. Pharmacoepidemiology and drug safety (2023)
Marjon V Verschueren, Talitha Dijs, Judith L Gulikers, Ard van Veelen, Sander Croes, Lizza E L Hendriks, Adrianus Aj Smit, Lourens T Bloem, Antoine C G Egberts, Ewoudt M W van de Garde, Bas Jm Peters
Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results. Immunotherapy (2023)
Judith L Gulikers, A J van Veelen, E M J Sinkiewicz, Y M de Beer, M Slikkerveer, L M L Stolk, V C G Tjan-Heijnen, L E L Hendriks, S Croes, R M J M van Geel
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasma. Biomedical chromatography : BMC (2023)